Welcome to the international HTA database

Showing [23369 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2015	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Hysteroscopy for abnormal uterine bleeding: review of clinical evidence and guidelines
2015	Institute for Clinical Evaluative Sciences (ICES)	Atlas of childhood cancer in Ontario 1985-2004
2015	National Evidence-based Healthcare Collaborating Agency (NECA)	[Analysis for healthcare safety management system]
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Glycerol phenylbutyrate (Ravicti) for urea cycle disorders (hyperammonaemia)
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	23g and 25g vitrectomy for eye conditions
2015	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	And another test title
2015	National Evidence-based Healthcare Collaborating Agency (NECA)	[Clinical safety and effectiveness of robotic surgery (2)]
2015	NIHR Horizon Scanning Centre (NIHR HSC)	GSK2696273 for severe combined immunodeficiency due to adenosine deaminase deficiency
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	Actigraphy in sleep disorder assessment
2015	Basque Office for Health Technology Assessment (OSTEBA)	[Ophthalmic implants in glaucoma surgery. Safety and effectiveness analysis]
2015	National Evidence-based Healthcare Collaborating Agency (NECA)	[Pilot study for understanding the present situation of decorative tattoos]
2015	Canadian Agency for Drugs and Technologies in Health (CADTH)	Holkira (ombitasvir/paritaprevir/ ritonavir with dasabuvir) and Harvoni (ledipasvir/sofosbuvir) for chronic hepatitis C: a review of the clinical evidence
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Lopixibat for progressive familial intrahepatic cholestasis in paediatric patients
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	Gene panels in autistic spectrum disorders
2015	Basque Office for Health Technology Assessment (OSTEBA)	[Cost effective analysis of negative pressure wound therapy for the treatment of venous ulcers in legs]
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Ocular biometry of the anterior chamber depth using IOL Master® and Pentacam®]
2015	National Evidence-based Healthcare Collaborating Agency (NECA)	[Research for extending the scope of health technology assessment (HTA): focusing on tobacco control]
2015	Canadian Agency for Drugs and Technologies in Health (CADTH)	Vitamin D testing in the general population: a review of the clinical and cost-effectiveness and guidelines
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Masitinib for Crohn's disease, in patients intolerant or with an unsatisfactory response to immunosuppressive drugs and/or TNF-inhibitors
2015	Basque Office for Health Technology Assessment (OSTEBA)	[E-health systems to support cancer patients: proposal for the design of future assessment studies]
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Exantia® tissue bulking agent for the treatment of fecal incontinence]
2015	National Evidence-based Healthcare Collaborating Agency (NECA)	[NECA Round Table Conference for social consensus]
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Masitinib for primary and relapse-free secondary progressive multiple sclerosis – first line
2015	Basque Office for Health Technology Assessment (OSTEBA)	[Arthroscopy with joint washout in the treatment of knee arthrosis]
2015	Finnish Office for Health Care Technology Assessment (Finohta)	[Role of fractional exhaled nitric oxide (FeNO) measurement in the management of asthma with corticosteroids]
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Biologic agents for the treatment of psoriasis]
2015	National Evidence-based Healthcare Collaborating Agency (NECA)	[Priority setting for health technology assessment(HTA) research in Korea]
2015	Canadian Agency for Drugs and Technologies in Health (CADTH)	Telehealth services for the treatment of psychiatric issues: clinical effectiveness, safety, and guidelines
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Masitinib for rheumatoid arthritis – second and subsequent line
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Ranibizumab, bevacizumab and aflibercept for age-related macular degeneration]
2015	National Evidence-based Healthcare Collaborating Agency (NECA)	[A construction of support scheme for health technology evidence-generation in Korea]
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Sirukumab for rheumatoid arthritis
2015	NIHR Health Technology Assessment programme	A feasibility randomised controlled trial of a motivational interviewing-based intervention for weight loss maintenance in adults
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Haploidentical bone marrow transplantation in patients with blood cancers]
2015	National Evidence-based Healthcare Collaborating Agency (NECA)	[The economic analysis of robotic surgery for prostate cancer]
2015	Canadian Agency for Drugs and Technologies in Health (CADTH)	Electroconvulsive therapy performed outside of surgical suites: a review of the clinical effectiveness, safety, and guidelines
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Tadalafil (Cialis) for Duchenne muscular dystrophy
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Subcutaneous histamine in migraine prevention]
2015	Technology Assessment at SickKids (TASK)	Thiopurine S-methyltransferase testing for averting drug toxicity in patients receiving thiopurines: A systematic review and quality appraisal
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Ataluren (Translarna) for CFTR class I nonsense mutation mediated cystic fibrosis
2015	NIHR Health Services and Delivery Research programme	Secondary analysis and literature review of community rehabilitation and intermediate care: an information resource
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Calreticulin gene mutation testing in myeloproliferative neoplasms]
2015	Technology Assessment at SickKids (TASK)	Thiopurine S-methyltransferase testing for averting drug toxicity in patients receiving thiopurines: A meta-analysis of diagnostic test accuracy
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Benralizumab for uncontrolled asthma – second line
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Ozone therapy for the treatment of lumbar disc disease]
2015	Agency for Healthcare Research and Quality (AHRQ)	Emerging approaches to diagnosis and treatment of non–muscle-invasive bladder cancer
2015	Canadian Agency for Drugs and Technologies in Health (CADTH)	Immediate osseointegrated implants for cancer patients: a review of clinical and cost-effectiveness
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Abiraterone (Zytiga) for hormone-naïve metastatic prostate cancer – first line
2015	Health Council of the Netherlands Gezondheidsraad (GR)	Next generation sequencing in diagnosis
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Efficacy of early intensive behavioral intervention in autism spectrum disorders]
2015	HAYES, Inc.	Continuous glucose monitoring systems
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Bevacizumab (Avastin) with lomustine for glioblastoma – second line
2015	Health Council of the Netherlands Gezondheidsraad (GR)	Checking checked: appropriate use of health checks
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Power Doppler for inflammatory arthropathies]
2015	HAYES, Inc.	Digital breast tomosynthesis for breast cancer diagnosis and screening
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Dacomitinib for locally advanced or metastatic EGFR positive non-small cell lung cancer – first line
2015	Health Council of the Netherlands Gezondheidsraad (GR)	Adriamycine. Health-based calculated occupational cancer risk values
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Brentuximab vedotin for relapsed or refractory Hodgkin's lymphoma]
2015	HAYES, Inc.	Endoscopic therapy for gastroesophageal reflux disease
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Fulvestrant (Faslodex) for advanced or metastatic, hormone-receptor positive breast cancer – first line
2015	Health Council of the Netherlands Gezondheidsraad (GR)	Neonatal screening: new recommendations
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Endovascular repair in abdominal aortic aneurysm]
2015	HAYES, Inc.	Intensity modulated radiation therapy (IMRT) for anal or rectal cancer
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Idelalisib (Zydelig) with bendamustine and rituximab for chronic lymphocytic leukaemia – first line
2015	Health Council of the Netherlands Gezondheidsraad (GR)	Population Screening Act: study of faecal tests within the population based screening programme for colorectal cancer
2015	Health Quality Ontario (HQO)	Positional Magnetic Resonance Imaging for people with Ehlers-Danlos Syndrome or suspected craniovertebral or cervical spine abnormalities: an evidence-based analysis
2015	HAYES, Inc.	Lumbar total disc replacement for degenerative disc disease
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Nivolumab (Opdivo) for diffuse large B cell lymphoma –second line
2015	NIHR Public Health Research (PHR) programme	How effective are interventions at reducing socioeconomic inequalities in obesity among children and adults? Two systematic reviews
2015	Health Council of the Netherlands Gezondheidsraad (GR)	Antibiotics in hospitals: prophylaxis and antibiotic stewardship
2015	Health Quality Ontario (HQO)	Positional magnetic resonance imaging for people with Ehlers-Danlos syndrome or suspected craniovertebral or cervical spine abnormalities: OHTAC recommendation
2015	HAYES, Inc.	PCSK9 inhibitors for cholesterol reduction: evolocumab
2015	Canadian Agency for Drugs and Technologies in Health (CADTH)	Transoral robotic surgery: a review of clinical and cost-effectiveness
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Nivolumab for recurrent glioblastoma – second line
2015	Agency for Healthcare Research and Quality (AHRQ)	Cognitive outcomes after cardiovascular procedures in older adults: a systematic review
2015	Health Council of the Netherlands Gezondheidsraad (GR)	Chlorpromazine - Evaluation of the effects on reproduction, recommendation for classification
2015	Institute of Health Economics (IHE)	Rheumatoid arthritis in a policy perspective: a registry for research and better treatment of Albertans
2015	HAYES, Inc.	Percutaneous left appendage closure to reduce stroke risk in patients with atrial fibrillation
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Nivolumab (Opdivo) for Hodgkin lymphoma in brentuximab treated patients – second line
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Crizotinib (Xalkori) for ALK-positive, locally advanced or metastatic, non-small cell lung cancer — first line
2015	Agency for Healthcare Research and Quality (AHRQ)	Routine iron supplementation and screening for iron deficiency anemia in pregnant women
2015	HAYES, Inc.	Second-wave direct-acting antivirals for hepatitis C: ledipasvir-sofosbuvir
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Nivolumab (Opdivo) for Hodgkin lymphoma in brentuximab naïve patients – second line
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Erythrocyte encapsulated asparaginase (GRASPA) for acute lymphoblastic leukaemia — second line
2015	Agency for Healthcare Research and Quality (AHRQ)	Management strategies to reduce psychiatric readmissions
2015	Institute of Health Economics (IHE)	Optimizing adoption and diffusion of medical devices at the system level
2015	HAYES, Inc.	Second-wave direct-acting antivirals for hepatitis C: sofosbuvir
2015	Canadian Agency for Drugs and Technologies in Health (CADTH)	Protein testing in patients with multiple myeloma: a review of clinical effectiveness and guidelines
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Nivolumab (Opdivo) for recurrent or metastatic squamous cell carcinoma of the head and neck – second line
2015	The Swedish Council on Health Technology Assessment (SBU)	[Newer antipsychotics for maintenance treatment of bipolar disorder]
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Ipilimumab (Yervoy) with paclitaxel and carboplatin for stage IV or recurrent non-small cell lung cancer
2015	Agency for Healthcare Research and Quality (AHRQ)	Core functionality for pediatric electronic health records
2015	HAYES, Inc.	Transcatheter surgical valve implantation (TAVI) versus surgical aortic valve replacement (SAVR) for aortic stenosis
2015	Canadian Agency for Drugs and Technologies in Health (CADTH)	Stool antigen tests for helicobacter pylori infection: a review of clinical and cost-effectiveness and guidelines
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Olaratumab with doxorubicin for advanced soft tissue sarcoma
2015	The Swedish Council on Health Technology Assessment (SBU)	[Post-mortem imaging]
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Ipilimumab (Yervoy) for chemotherapy-naïve hormone-relapsed metastatic prostate cancer
2015	NIHR Health Technology Assessment programme	Treatment of childhood anxiety disorder in the context of maternal anxiety disorder: a randomised controlled trial and economic analysis
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Panel antibody detection for idiopathic inflammatory myopathies]
2015	HAYES, Inc.	Ultrasound bone growth stimulation